{"category":{"kind":"industry","slug":"animal-health","name":"Animal Health","tagline":null,"description":null,"synonyms":[],"target_queries":[],"added_via":"web","added_at":"2026-10-22T22:20:29.321Z","updated_at":"2026-10-22T22:20:29.321Z","example":false,"profile_url":"/industries/animal-health","is_stub":true,"member_count":2,"member_counts":{"company":2}},"members":[{"listing_type":"company","name":"Warhound","slug":"warhound","tagline":"Advanced canine genetics and cybernetics platform for elite working dogs","description":"Warhound is a Texas-based defense technology company conceived by Colossal Biosciences CEO Ben Lamm and Anduril co-founder Palmer Luckey, and led by CEO David Spirk, previously the U.S. Department of Defense's first chief data officer. It aims to rebuild America's domestic supply of working dogs for the military, law enforcement and emergency response by biobanking and cloning top-performing dogs, using licensed Colossal genetics technology to improve traits such as health and performance, and equipping the dogs with Anduril hardware and software. Its training programs are certified by the American Humane Society. Warhound emerged from stealth in October 2026 with a $200 million seed round at a reported $1.2 billion valuation, backed by investors including Sequoia Capital, In-Q-Tel, ARK Invest, 8VC and Lux Capital.","url":"https://warhound.com/","is_stealth":false,"normalized_domain":"warhound.com","normalized_url_key":"warhound.com","parent_slug":null,"parent":null,"type_data":{},"logo":"https://warhound.com/favicon.ico","links":[{"label":"Launch announcement (PR Newswire)","url":"https://www.prnewswire.com/news-releases/warhound-launches-with-200-million-to-rebuild-americas-military-working-dog-supply-using-advanced-genetics-and-defense-technology-302917498.html"},{"label":"TechCrunch: Warhound raises $200M","url":"https://techcrunch.com/2026/10/22/ben-lamm-raises-200m-for-warhound-to-engineer-war-dogs-and-arm-them-with-anduril-gear/"}],"entry_points":[{"kind":"homepage","url":"https://warhound.com/","audience":"human","primary":true,"listed_by":"community","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://warhound.com/","audience":"human","primary":true,"listed_by":"community","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Defense Tech","Biotech","Genetics","Animal Health"],"stage":null,"founded_year":null,"location":null,"pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-10-23T01:19:12.248Z","added_via":"web","geo":null,"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-10-23T01:19:12.248Z","is_featured":false,"category_memberships":[{"kind":"industry","slug":"animal-health","name":"Animal Health","note":null,"profile_url":"/industries/animal-health"},{"kind":"industry","slug":"biotech","name":"BioTech","note":null,"profile_url":"/industries/biotech"},{"kind":"industry","slug":"defense-tech","name":"Defense Tech","note":null,"profile_url":"/industries/defense-tech"},{"kind":"industry","slug":"genetics","name":"Genetics","note":null,"profile_url":"/industries/genetics"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-10-23T01:19:12.248Z","updated_at":"2026-10-23T01:19:12.248Z"}},{"listing_type":"company","name":"Familiar Therapeutics","slug":"familiar-therapeutics","tagline":"Brings proven human medicines to dogs and cats through FDA approval","description":"Familiar Therapeutics is a Redwood City, California biotech company that licenses the veterinary rights to drugs already researched for human disease from pharmaceutical and biotech partners, then leads the clinical development, manufacturing and FDA Center for Veterinary Medicine work needed to get them approved for dogs and cats. Founded in 2026 by Elizabeth Iorns and Dan Knox (co-founders of Science Exchange), it says it has built four lead and nine earlier-stage programs spanning oncology, neurology, cardiology, respiratory disease and immunology. Its lead program, FAM-010, targets canine hemangiosarcoma, a cancer with no FDA-approved treatment, with a pilot study planned at the University of Illinois College of Veterinary Medicine. It launched in October 2026 with a $5 million seed round led by Pioneer Fund, Icehouse Ventures and BreakTHRU.","url":"https://familiartx.com/","is_stealth":false,"normalized_domain":"familiartx.com","normalized_url_key":"familiartx.com","parent_slug":null,"parent":null,"type_data":{},"logo":"https://familiartx.com/favicon.ico","links":[{"label":"X","url":"https://x.com/FamiliarTx","platform":"x"},{"label":"Launch announcement (Business Wire via Yahoo Finance)","url":"https://finance.yahoo.com/healthcare/articles/familiar-therapeutics-launches-5-million-121200253.html"}],"entry_points":[{"kind":"homepage","url":"https://familiartx.com/","audience":"human","primary":true,"listed_by":"community","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://familiartx.com/","audience":"human","primary":true,"listed_by":"community","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Biotech","Animal Health","Veterinary","Drug Development"],"stage":null,"founded_year":null,"location":null,"pricing":null,"twitter":null,"github":null,"linkedin":"https://www.linkedin.com/company/familiartx/","contact_email":null,"added_at":"2026-10-22T22:20:29.321Z","added_via":"web","geo":null,"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-10-22T22:21:24.739Z","is_featured":false,"category_memberships":[{"kind":"industry","slug":"animal-health","name":"Animal Health","note":null,"profile_url":"/industries/animal-health"},{"kind":"industry","slug":"biotech","name":"BioTech","note":null,"profile_url":"/industries/biotech"},{"kind":"industry","slug":"drug-development","name":"Drug Development","note":null,"profile_url":"/industries/drug-development"},{"kind":"industry","slug":"veterinary","name":"Veterinary","note":null,"profile_url":"/industries/veterinary"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-10-22T22:20:29.321Z","updated_at":"2026-10-22T22:20:29.321Z"}}],"total":2,"limit":50,"offset":0}